Sagir A - Search Results

1

SEN Virus infection in HIV/HCV coinfected patients.

Sagir A, Adams O, Oette M, Vogel M, Kupfer B, Emmelkamp J, Rockstroh J, Häussinger D. Sagir A, et al. Eur J Med Res. 2008 Nov 24;13(11):495-9. Eur J Med Res. 2008. PMID: 19073384

2

Atazanavir for treatment of HIV infection in clinical routine: efficacy, pharmacokinetics and safety.

Feldt T, Oette M, Kroidl A, Göbels K, Leidel R, Sagir A, Kuschak D, Häussinger D. Feldt T, et al. Among authors: sagir a. Eur J Med Res. 2005 Jan 28;10(1):7-10. Eur J Med Res. 2005. PMID: 15737947 Clinical Trial.

3

Wireless capsule endoscopy for the detection of small bowel diseases in HIV-1-infected patients.

Oette M, Stelzer A, Göbels K, Wettstein M, Sagir A, Feldt T, Häussinger D. Oette M, et al. Among authors: sagir a. Eur J Med Res. 2009 May 14;14(5):191-4. doi: 10.1186/2047-783x-14-5-191. Eur J Med Res. 2009. PMID: 19541574 Free PMC article. Clinical Trial.

4

Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine.

Erhardt A, Sagir A, Guillevin L, Neuen-Jacob E, Häussinger D. Erhardt A, et al. Among authors: sagir a. J Hepatol. 2000 Oct;33(4):677-83. doi: 10.1034/j.1600-0641.2000.033004677.x. J Hepatol. 2000. PMID: 11059878

5

Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D.

Erhardt A, Blondin D, Hauck K, Sagir A, Kohnle T, Heintges T, Häussinger D. Erhardt A, et al. Among authors: sagir a. Gut. 2005 Jul;54(7):1009-13. doi: 10.1136/gut.2004.060327. Gut. 2005. PMID: 15951551 Free PMC article.

6

Impact of rosiglitazone treatment on the bioavailability of antiretroviral compounds in HIV-positive patients.

Oette M, Kurowski M, Feldt T, Kroidl A, Sagir A, Vogt C, Wettstein M, Häussinger D. Oette M, et al. Among authors: sagir a. J Antimicrob Chemother. 2005 Aug;56(2):416-9. doi: 10.1093/jac/dki234. Epub 2005 Jun 27. J Antimicrob Chemother. 2005. PMID: 15983027

7

[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].

Oette M, Kaiser R, Däumer M, Fätkenheuer G, Rockstroh JK, Knechten H, Mitrenga D, Beerenwinkel N, Sagir A, Pfister H, Häussinger D. Oette M, et al. Among authors: sagir a. Dtsch Med Wochenschr. 2007 May 4;132(18):977-82. doi: 10.1055/s-2007-979365. Dtsch Med Wochenschr. 2007. PMID: 17457780 German.

8

Therapy outcome in patients with chronic hepatitis C: role of therapy supervision by expert hepatologists.

Sagir A, Heintges T, Akyazi Z, Oette M, Erhardt A, Häussinger D. Sagir A, et al. J Viral Hepat. 2007 Sep;14(9):633-8. doi: 10.1111/j.1365-2893.2007.00854.x. J Viral Hepat. 2007. PMID: 17697015

9

[New approaches in the treatment of hepatitis B].

Sagir A, Avci A, Erhardt A, Lörke J, Heintges T, Häussinger D. Sagir A, et al. Dtsch Med Wochenschr. 2004 May 21;129(21):1203-8. doi: 10.1055/s-2004-824872. Dtsch Med Wochenschr. 2004. PMID: 15160325 Review. German. No abstract available.

10

Retrospective analysis of chronic hepatitis D in a West German University Clinic over two decades: migratory pattern, prevalence and clinical outcome.

Erhardt A, Hoernke M, Heinzel-Pleines U, Sagir A, Göbel T, Häussinger D. Erhardt A, et al. Among authors: sagir a. Z Gastroenterol. 2010 Aug;48(8):813-7. doi: 10.1055/s-0028-1109984. Epub 2010 Aug 4. Z Gastroenterol. 2010. PMID: 20687016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters